Bristol-Myers, uniQure enter cardiovascular gene therapy deal – Pharmaceutical Business Review

Bristol-Myers, uniQure enter cardiovascular gene therapy deal – Pharmaceutical Business Review

Bristol-Myers Squibb (BMS) and Netherlands-based uniQure have entered into exclusive strategic collaboration to develop gene therapies for cardiovascu

Source: drugdiscovery.pharmaceutical-business-review.com



Comments are closed.